Riviclav 625mg Details

Riviclav 625mg

PERFECT WINNER

URTIs, LRTs, Tonsilitis, Sinusitis, AOM, SOM, SSTI


  • Recommended as empirical therapy in RTIs.
  • Offers 94% efficacy in chronic bronchitis.
  • Offers 98% clinical efficacy in AOM.
  • Internationally Acclaimed Product

Ensures

  • Proper Stability of drugs 100%
  • Protection from Air, Light, Moist
  • Effective Tolerance
  • Effective Bioavailability